Boston Scientific's DBS system shows treatment effect in Parkinson's patients; shares up 1% premarket [Seeking Alpha]
Boston Scientific Corporation (BSX)
Last boston scientific corporation earnings: 4/29 06:30 am
Check Earnings Report
US:NYSE Investor Relations:
investors.bostonscientific.com
Company Research
Source: Seeking Alpha
Boston Scientific's DBS system shows treatment effect in Parkinson's patients; shares up 1% premarketBoston Scientific (NYSE:BSX) is up1% premarket on light volume in response to itsannouncement of results from the INTREPID study assessing its VERCISE deep brain stimulation (DBS) system for the treatment of advanced levodopa-responsive Parkinson's disease (PD). The data are being presented at the American Academy of Neurology Annual Meeting in Los Angeles.PD patients treated with VERCISE experienced a 49.2% improvement in motor symptoms, a six-hour improvement in "on time" with dyskinesias and sustained improvement in quality of life measures.The FDA approved the device in December 2017.Previously:FDA OKs Boston Sci's deep brain stimulation system; shares ahead 2% premarket (Dec. 12, 2017)See all stocks on the move »Now read:Valuation Dashboard: Healthcare - Update »
Show less
Read more
Impact Snapshot
Event Time:
BSX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BSX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BSX alerts
High impacting Boston Scientific Corporation news events
Weekly update
A roundup of the hottest topics
BSX
News
- Boston Scientific Co. (NYSE: BSX) had its price target raised by analysts at Needham & Company LLC from $71.00 to $82.00. They now have a "buy" rating on the stock.MarketBeat
- Boston Scientific Lifts 2024 Profit Forecast On Strong Growth From Cardiovascular Devices, Stock Soars [Yahoo! Finance]Yahoo! Finance
- Boston Scientific (BSX) Q1 Earnings Beat Estimates, View Raised [Yahoo! Finance]Yahoo! Finance
- Boston Scientific (BSX) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates [Yahoo! Finance]Yahoo! Finance
- Here's Why Boston Scientific Corporation (BSX) Rose in Q1 [Yahoo! Finance]Yahoo! Finance
BSX
Earnings
- 4/24/24 - Miss
BSX
Sec Filings
- 4/24/24 - Form 8-K
- 4/4/24 - Form 8-K
- 4/2/24 - Form 4
- BSX's page on the SEC website